Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Mucopolysaccharidosis Market - A Global and Regional Analysis: Focus on Treatment, Disease Type, Route of Administration, End User, Country, and Region - ...
FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment PR Newswire PARAMUS, N.J., May 14, 2025 ...
Medipal Holdings Corp. and JCR Pharmaceuticals Co. Ltd. have announced the completion of the clinical trial notification review by Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for a phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback